Anders Jacobson
Director/Board Member bij KLARIA PHARMA HOLDING AB
Vermogen: 6 378 $ op 31-03-2024
Profiel
Anders Jacobson is currently the Deputy Chairman at MD Biomedical AB.
He is also an Independent Director at Klaria Pharma Holding AB and the Chief Innovation Officer at Senzime AB.
Previously, he served as a Director at Acarix AB from 2020 to 2021.
Mr. Jacobson holds a graduate degree from the University of Uppsala.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SENZIME AB
0.01% | 30-12-2022 | 11 000 ( 0.01% ) | 6 378 $ | 31-03-2024 |
Actieve functies van Anders Jacobson
| Bedrijven | Functie | Begin |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01-02-2022 |
| KLARIA PHARMA HOLDING AB | Director/Board Member | 01-01-2022 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The private company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Director/Board Member | - |
Eerdere bekende functies van Anders Jacobson
| Bedrijven | Functie | Einde |
|---|---|---|
| ACARIX AB | Director/Board Member | 11-05-2021 |
Opleiding van Anders Jacobson
| University of Uppsala | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SENZIME AB | Health Technology |
| ACARIX AB | Health Technology |
| KLARIA PHARMA HOLDING AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The private company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
